Resveratrol against major pathologies: From diet prevention to possible alternative chemotherapies with new structural analogues

Bioactive Compounds from Natural Sources: Natural Products as Lead Compounds in Drug Discovery, Second Edition

Volumn , Issue , 2011, Pages 339-378

  Latruffe, Norbert ^a   Delmas, Dominique ^a   Lizard, Gérard ^a   Tringali, Corrado ^b   Spatafora, Carmela ^b   Vervandier Fasseur, Dominique ^a   Meunier, Philippe ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84948812352     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (210)

1. Adrian, M., Jeandet, P., Douillet-Breuil, A.C., Tesson, L., and Bessis, R. 2000. Stilbene content of mature Vitis vinifera berries in response to UV-C elicitation. J. Agric. Food Chem. 48: 6103-6105.
2. Aggarwal, B.B. and Shishodia, S. 2006. Resveratrol in health and disease. In Oxidative Stress and Disease, Vol. 20, Taylor & Francis, London, U.K., pp. 1-712.
3. Ahmad, A., Syed, F.A., Singh, S., and Hadi, S.M. 2005. Prooxidant activity of resveratrol in the presence of copper ions: Mutagenicity in plasmid DNA. Toxicol. Lett. 159: 1-12.
4. Ahn, J.S., Lee, J.H., Kim, J.H., and Paik, S.R. 2007. Novel method for quantitative determina¬tion of amyloid fibrils of α-synuclein and amyloid β/A4 protein by using resveratrol. Anal. Biochem. 367: 259-265.
5. Andlauer, W., Kolb, J., Siebert, K., and Fürst, P. 2000. Assessment of resveratrol bioavailabil¬ity in the perfused small intestine of the rat. Drugs Exp. Clin. Res. 26: 47-45.
6. Asensi, M., Medina, I., Ortega, A., Carretero, J., Bano, M.C., Obrador, E., and Estrela, J.M. 2002. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic. Biol. Med. 33: 387-398.
7. Ates, O., Cayli, S., Altinoz, E., Gurses, I., Yucel, N., Kocak, A., Yologlu, S., and Turkoz, Y. 2006. Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury. Acta Pharmacol. Sin. 27: 1317-1325.
8. Ates, O., Cayli, S.R., Yucel, N., Altinoz, E., Kocak, A., Durak, M.A., Turkoz, Y., and Yologlu, S. 2007. Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J. Clin. Neurosci. 14: 256-260.
9. Aumont, V., Krisa, S., Battaglia, E., Netter, P., Richard, T., Merillon, J.M., Magdalou, J., and Sabolovic, N. 2001. Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human. Arch. Biochem. Biophys. 393: 281-289.
10. Azmi, A.S., Bhat, S.H., Hanif, S., and Hadi, S.M. 2006. Plant polyphenols mobilize endog¬enous copper in human peripheral lymphocytes leading to oxidative DNA breakage: A putative mechanism for anticancer properties. FEBS Lett. 580: 533-538.
11. Bastianetto, S., Dumont, Y., Han, Y., and Quirion, R. 2009. Comparative neuroprotective prop¬erties of stilbene and catechin analogs: Action via a plasma membrane receptor site? CNS Neurosci. Ther. 15: 76-83.
12. Baur, J.A. and Sinclair, D.A. 2006. Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 5: 493-506.
13. Belguendouz, L., Fremont, L., and Linard, A. 1997. Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low density lipoproteins. Biochem. Pharmacol. 53: 1347-1355.
14. Bernhard, D., Tinhofer, I., Tonko, M., Hubl, H., Ausserlechner, M.J., Greil, R., Kofler, R., and Csordas, A. 2000. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell. Death Differ. 7: 834-842.
15. Bertelli, A., Bertelli, A.A.E., Gozzini, A., and Giovannini, L. 1998. Plasma and tissue resveratrol concentrations and pharmacological activity. Drug Exp. Clin. Res. 24: 133-138.
16. Bhat, S.H., Azmi, A.S., and Hadi, S.M. 2007. Prooxidant DNA breakage induced by caffeic acid in human peripheral lymphocytes: Involvement of endogenous copper and a puta¬tive mechanism for anticancer properties. Toxicol. Appl. Pharmacol. 218: 249-255.
17. Biasutto, L., Mattarei, A., Marotta, E., Bradaschia, A., Sassi, N., Garbisa, S., Zoratti, M., and Paradisi, C. 2008. Development of mitochondria-targeted derivatives of resveratrol. Bioorg. Med. Chem. Lett. 18: 5594-5597.
18. Billard, C., Izard, J.C., Roman, V., Kern, C., Mathiot, C., Mentz, F., and Kolb, J.P. 2002. Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukemia cells and normal human lymphocytes. Leuk. Lymphoma 43: 1991-2002.
19. Botella, L. and Najera, C. 2004. Synthesis of methylated resveratrol and analogues by Heck reactions in organic and aqueous solvents. Tetrahedron 60: 5563-5570.
20. Brito, P.M., Mariano, A., Almeida, L.M., and Dinis, T.C. 2006. Resveratrol affords protection against peroxynitrite-mediated endothelial cell death: A role for intracellular glutathi¬one. Chem. Biol. Interact. 164: 157-166.
21. Buryanovskyy, L., Fu, Y., Boyd, M., Ma, Y., Hsieh, T.C., Wu, J.M., and Zhang, Z. 2004. Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 43: 11417-11426.
22. Cai, J.B., Zhang, Z.H., Xu, D.J., Qian, Z.Y., Wang, Z.R., Huang, Y.Z., Zou, J.G., and Cao, K.J. 2008. Negative regulation of quinone reductase 2 by resveratrol in cultured vascular smooth muscle. Clin. Exp. Pharm. Phys. 35: 1419-1425.
23. Cao, Z. and Li, Y. 2004. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: Protection against oxidative and electrophilic injury. Eur. J. Pharmacol. 489: 39-48.
24. Cardile, V., Chillemi, R., Lombardo, L., Sciuto, S., Spatafora, C., and Tringali, C. 2007. Antiproliferative activity of methylated analogues of E and Z-resveratrol. Z. Naturforsch. (C) 62: 189-195.
25. Cardile, V., Lombardo, L., Spatafora, C., and Tringali, C. 2005. Chemoenzymatic synthesis and cell growth inhibition activity of resveratrol analogues. Bioorg. Chem. 33: 22-33.
26. Cardile, V., Scifo, C., Russo, A., Falsaperla, M., Morgia, G., Motta, M., Renis, M., Imbriani, E., and Silvestre, G. 2003. Involvement of HSP70 in resveratrol-induced apoptosis of human prostate cancer. Anticancer Res. 23: 4921-4926.
27. Casper, R.F., Quesne, M., Rogers, I.M., Shirota, T., Jolivet, A., Milgrom, E., and Savouret, J.F. 1999. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: Implications for prevention of dioxin toxicity. Mol. Pharmacol. 56: 784-790.
28. Chávez, E., Reyes-Gordillo, K., Segovia, J., Shibayama, M., Tsutsumi, V., Vergara, P., Moreno, M.G., and Muriel, P. 2008. Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats. J. Appl. Toxicol. 28: 35-43.
29. Chen, T., Li, J., Cao, J., Xu, Q., Komatsu, K., and Namba, T. 1999. A new flavanone isolated from Rhizoma smilacis glabrae and the structural requirements of its derivatives for preventing immunological hepatocyte damage. Planta Med. 65: 56-59.
30. Chen, L., Zhang, Y., Sun, X., Li, H., Lesage, G., Javer, A., Zhang, X., Wei, X., Jiang, Y., and Yin, D. 2009. Synthetic resveratrol aliphatic acid inhibits TLR2-mediated apoptosis and an involvement of Akt/GSK3b pathway. Bioorg. Med. Chem. 17: 4378-4382.
31. Chillemi, R., Sciuto, S., Spatafora, C., and Tringali, C. 2007. Anti-tumor properties of stil¬bene-based resveratrol analogues: Recent results. Nat. Prod. Commun. 2: 1-15.
32. Ciolino, H.P., Daschner, P.J., and Chao Jeh, G. 1998. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of aryl hydrocarbon receptor. Cancer Res. 58: 5707-5712.
33. Clement, M.V., Hirpara, J.L., Chawdhury, S.H., and Pervaiz, S. 1998. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996-1002.
34. Colin, D., Gimazane, A., Lizard, G., Izard, J.C., Solary, E., Latruffe, N., and Delmas, D. 2009. Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5-fluorouracil sensitivity in human derived colon cancer cells. Int. J. Cancer. 124: 2780-2788.
35. Colin, D., Lançon, A., Delmas, D., Abrosssinow, J., Kahn, E., Lizard, G., Jannin, B., and Latruffe, N. 2008. Comparative study of the cell uptake and the antiproliferative effects of resveratrol, epsilon-viniferin and their acetates. Biochimie 90: 1674-1684.
36. Curry, S., Brick, P., and Franck, N.P. 1999. Fatty acid binding to human serum albumin: New insights from crystallographic studies. Biochim. Biophys. Acta 1441: 131-140.
37. de Almeida, L.M., Piñeiro, C.C., Leite, M.C., Brolese, G., Tramontina, F., Feoli, A.M., Gottfried, C., and Gonçalves, C.A. 2007. Resveratrol increases glutamate uptake, gluta¬thione content, and S100B secretion in cortical astrocyte cultures. Cell. Mol. Neurobiol. 27: 661-668.
38. de la Lastra, C.A. and Villegas, I. 2005. Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications. Mol. Nutr. Food. Res. 49: 405-430.
39. de la Lastra, C.A. and Villegas, I. 2007. Resveratrol as an anti-oxidant and pro-oxidant agent: Mechanisms and clinical implications. Biochem. Soc. Trans. 35: 1156-1160.
40. de Lima, D.P., Rotta, R., Beatriz, A., Marques, M.R., Montenegro, R.C., Vasconcellos, M.C., Pessoa, C., de Moraes, M.O., Costa-Lotufo, L.V., Frankland Sawaya, A.C., and Eberlin, M.N. 2009. Synthesis and biological evaluation of cytotoxic properties of stilbenes based resveratrol analogs. Eur. J. Med. Chem. 44: 701-707.
41. Delmas, D., Jannin, B., Malki, M.C., and Latruffe, N. 2000. Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines. Oncol. Rep. 7: 847-852.
42. Delmas, D., Lançon, A., Colin, D., Jannin, B., and Latruffe, N. 2006. Resveratrol as a che¬mopreventive agent a promising molecule for fighting cancer. Curr. Drug Targets 7: 423-442.
43. Delmas, D., Passilly-Degrace, P., Jannin, B., Malki, M.C., and Latruffe, N. 2002. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. Int. J. Mol. Med. 10: 193-199.
44. Delmas, D., Rebe, C., Lacour, S., Filomenko, R., Athias, A., Gambert, P., Cherkaoui-Malki, M., Jannin, B., Dubrez-Daloz, L., Latruffe, N., and Solary, E. 2003. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J. Biol. Chem. 278: 41482-41490.
45. Delmas, D., Rebe, C., Micheau, O., Athias, A., Gambert, P., Grazide, S., Laurent, G., Latruffe, N., and Solary, E. 2004. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 23: 8979-8986.
46. Dorrie, J., Gerauer, H., Wachter, Y., and Zunino, S.J. 2001. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res. 61: 4731-4739.
47. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42.
48. Elleingand, E., Gerez, C., Un, S., Knupling, M., Lu, G., Salem, J., Rubin, H., Sauge-Merle, S., Laulhere, J.P., and Fontecave, M. 1998. Reactivity studies of the tyrosyl radical in ribonucleotide reductase from Mycobacterium tuberculosis and Arabidopsis thaliana-Comparison with Escherichia coli and mouse. Eur. J. Biochem. 258: 485-490.
49. Erenpreisa, J., Kalejs, M., and Cragg, M.S. 2005. Mitotic catastrophe and endomitosis in tumour cells: An evolutionary key to a molecular solution. Cell Biol. Int. 29: 1012-1018.
50. Evers, D.L., Wang, X., Huong, S.M., Huang, D.Y., and Huang, E.S. 2004. 3,4′,5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling. Antiviral Res. 63: 85-95.
51. Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C., and Guittet, O. 1998. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421: 277-279.
52. Fuggetta, M.P., D’Atri, S., Lanzilli, G., Tricarico, M., Cannavo, E., Zambruno, G., Falchetti, R., and Ravagnan, G. 2004. In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. Melanoma Res. 14: 189-196.
53. Fukuhara, K. and Miyata, N. 1998. Resveratrol as a new type of DNA-cleaving agent. Bioorg. Med. Chem. Lett. 8: 3187-3192.
54. Fukuhara, K., Nagakawa, M., Nakanishi, I., Ohkubo, K., Imai, K., Urano, S., Fukuzumi, S., Ozawa, T., Ikota, N., Mochizuki, M., Miyata, N., and Okuda, H. 2006. Structural basis for DNA-cleaving activity of resveratrol in the presence of Cu(II). Bioorg. Med. Chem. 14: 1437-1443.
55. Fulda, S. and Debatin, K.M. 2004a. Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene 23: 6702-6711.
56. Fulda, S. and Debatin, K.M. 2004b. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res. 6: 337-346.
57. Gao, M., Wang, M., Miller, K.D., Sledge, G.W., Hutchins, G.D., and Zheng, Q.H. 2006. Synthesis of radiolabelled stilbene derivatives as new potential PET probes for aryl hydrocarbon receptor in cancers. Bioorg. Med. Chem. Lett. 16: 5767-5772.
58. Gao, X., Xu, Y.X., Divine, G., Janakiraman, N., Chapman, R.A., and Gautam, S.C. 2002. Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J. Nutr. 132: 2076-2081.
59. Glatz, J.F.G. and van der Vusse, G.J. 1996. Cellular fatty acid binding protein: Their function and physiological significance. Prog. Lip. Res. 35: 243-282.
60. Goldberg, D.M., Yan, J., and Soleas, G.J. 2003. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 36: 79-87.
61. Gupta, Y.K., Briyal, S., and Chaudhary, G. 2002. Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats. Pharmacol. Biochem. Behav. 71: 245-249.
62. Guy, R., Scott, Z., Sloboda, R., and Nicolaou, K. 1996. Fluorescent taxoids. Chem. Biol. 3: 1021-1031.
63. Hadi, S.M., Asad, S.F., Singh, S., and Ahmad, A. 2000. Putative mechanism for anticancer and apoptosis-inducing properties of plant-derived polyphenolic compounds. IUBMB Life 50: 167-171.
64. Haider, U.G., Sorescu, D., Griendling, K.K., Vollmar, A.M., and Dirsch, V.M. 2003. Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. Mol. Pharmacol. 63: 925-932.
65. Han, Y.S., Bastianetto, S., Dumont, Y., and Quirion, R. 2006. Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J. Pharmacol. Exp. Therap. 318: 238-245.
66. Hauss, F., Liu, J., Michelucci, A., Coowar, D., Morga, E., Heuschling, P., and Luu, B. 2007. Dual bioactivity of resveratrol fatty alcohols: Differentiation of neural stem cells and modulation of neuroinflammation. Bioorg. Med. Chem. Lett. 17: 4218-4222.
67. Hayashibara, T., Yamada, Y., Nakayama, S., Harasawa, H., Tsuruda, K., Sugahara, K., Miyanishi, T., Kamihira, S., Tomonaga, M., and Maita, T. 2002. Resveratrol induces downregulation in survivin expression and apoptosis in HTLV-1-infected cell lines: A prospective agent for adult T cell leukemia chemotherapy. Nutr. Cancer. 44: 193-201.
68. Henry, C., Vitrac, X., Decendit, A., Ennamany, R., Krisa, S., and Merillon, J.M. 2005. Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical mem¬brane of human intestinal Caco-2 cells. J. Agric. Food Chem. 53: 798-803.
69. Heynekamp, J.J. 2006. Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of tran¬scription factor nuclear factor Kappa B. J. Med. Chem. 49: 7182-7189.
70. Hosokawa, N., Hosokawa, Y., Sakai, T., Yoshida, M., Marui, N., Nishino, H., Kawai, K., and Aoike, A. 1990. Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17-kDa protein, in human colon cancer cells. Int. J. Cancer 45: 1119-1124.
71. Hsieh, T.C., Burfeind, P., Laud, K., Backer, J.M., Traganos, F., Darzynkiewicz, Z., and Wu, J.M. 1999b. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials. Int. J. Oncol. 15: 245-252.
72. Hsieh, T.C., Juan, G., Darzynkiewicz, Z., and Wu, J.M. 1999a. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21(WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59: 2596-2601.
73. Hsieh, T.C., Wang, Z., Hamby, C.V., and Wu, J.M. 2005. Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53. Biochem. Biophys. Res. Commun. 334: 223-230.
74. Huang, C., Ma, W.Y., Goranson, A., and Dong, Z. 1999. Resveratrol suppresses cell transfor¬mation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20: 237-242.
75. Hunter, T. and Pines, J. 1994. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582.
76. Hwang, J.T., Kwak, D.W., Lin, S.K., Kim, H.M., Kim, Y.M., and Park, O.J. 2007. Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway. Ann. N. Y. Acad. Sci. 1095: 441-448.
77. Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W., Fong, H.H., Farnsworth, N.R., Kinghorn, A.D., Mehta, R.G., Moon, R.C., and Pezzuto, J.M. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
78. Jang, J.H. and Surh, Y.J. 2001. Protective effects of resveratrol on hydrogen peroxide-induced apoptosis in rat pheochromocytoma (PC12) cells. Mutat. Res. 496: 181-190.
79. Jannin, B., Menzel, M., Berlot, J.-P., Delmas, D., Lançon, A., and Latruffe, N. 2004. Interactions of resveratrol, a chemopreventive agent, with serum albumin. Biochem. Pharmacol. 68: 1113-1118.
80. Jazirehi, A.R. and Bonavida, B. 2004. Resveratrol modifies the expression of apoptotic regula¬tory proteins and sensitizes non-Hodgkin’s lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol. Cancer Ther. 3: 71-84.
81. Jiang, Y.L. 2008. Design, synthesis and spectroscopic studies of resveratrol aliphatic acid ligands of human serum albumin. Bioorg. Med. Chem. 16: 6406-6414.
82. Juan, M.E., Wenzel, U., Daniel, H., and Planas, J.M. 2008. Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells. J. Agric. Food Chem. 56: 4813-4818.
83. Kaneuchi, M., Sasaki, M., Tanaka, Y., Yamamoto, R., Sakuragi, N., and Dahiya, R. 2003. Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF. Int. J. Oncol. 23: 1167-1172.
84. Kasdallah-Grissa, A., Mornagui, B., Aouani, E., Hammami, M., El May, M., Gharbi, N., Kamoun, A., and El-Fazaâ, S. 2007. Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci. 80: 1033-1039.
85. Kim, Y.A., Choi, B.T., Lee, Y.T., Park, D.I., Rhee, S.H., Park, K.Y., and Choi, Y.H. 2004. Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncol. Rep. 11: 441-446.
86. Kim, S., Min, S.Y., Lee, S.K., and Cho, W.J. 2003a. Comparative molecular field analysis study of stilbene derivatives active against A549 lung carcinoma. Chem. Pharm. Bull. 51: 516-521.
87. Kim, Y.A., Rhee, S.H., Park, K.Y., and Choi, Y.H. 2003b. Antiproliferative effect of resveratrol in human prostate carcinoma cells. J. Med. Food 6: 273-280.
88. Klinge, C.M., Blankenship, K.A., Risinger, K.E., Bhatnagar, S., Noisin, E.L., Sumanasekera, W.K., Zhao, L., Brey, D.M., and Keynton, R.S. 2005. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J. Biol. Chem. 280: 7460-7468.
89. Kluth, D., Banning, A., Paur, I., Blomhoff, R., and Brigelius-Flohé, R. 2007. Modulation of pregnane X receptor- and electrophile responsive element-mediated gene expression by dietary polyphenolic compounds. Free Radic. Biol. Med. 42: 315-325.
90. Kode, A., Rajendrasozhan, S., Caito, S., Yang, S.R., Megson, I.L., and Rahman, I. 2008. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L478-L488.
91. Kotha, A., Sekharam, M., Cilenti, L., Siddiquee, K., Khaled, A., Zervos, A.S., Carter, B., Turkson, J., and Jove, R. 2006. Resveratrol inhibits Src and Stat3 signaling and induces the apop¬tosis of malignant cells containing activated Stat3 protein. Mol. Cancer Ther. 5: 621-629.
92. Kumar, A., Naidu, P.S., Seghal, N., and Padi, S.S. 2007. Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 79: 17-26.
93. Kumar, P., Padi, S.S., Naidu, P.S., and Kumar, A. 2006. Effect of resveratrol on 3-nitropro¬pionic acid-induced biochemical and behavioural changes: Possible neuroprotective mechanisms. Behav. Pharmacol. 17: 485-492.
94. Kuo, P.L., Chiang, L.C., and Lin, C.C. 2002. Resveratrol- induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci. 72: 23-34.
95. Kuwajerwala, N., Cifuentes, E., Gautam, S., Menon, M., Barrack, E.R., and Reddy, G.P. 2002. Resveratrol induces prostate cancer cell entry into S phase and inhibits DNA synthesis. Cancer Res. 62: 2488-2492.
96. Lamuela-Raventos, R.M., Covas, M.I., Fito, M., Marrugat, J., and de la Torre-Boronat, M.C. 1999. Detection of dietary antioxidant phenolic compounds in human LDL. Clin. Chem. 45: 1870-1872.
97. Lançon, A., Delmas, D., Osman, H., Thénot, J.P., Jannin, B., and Latruffe, N. 2004. Human hepatic cell uptake of resveratrol: Involvement of both passive diffusion and carrier-mediated process. Biochem. Biophys. Res. Commun. 316: 1132-1137.
98. Lançon, A., Hanet, N., Jannin, B., Delmas, D., Heydel, J.M., Chagnon, M.C., Lizard, G., Artur, Y., and Latruffe, N. 2007. Resveratrol in human hepatoma HepG2 cells: Metabolism and inducibility of detoxifying enzymes. Drug. Metab. Dispos. 35: 699-703.
99. Langcake, P. and Pryce, R.J. 1976. The production of resveratrol by Vitis vinifera and other mem¬bers of the vitaceae as a response to infection or injury. Physiol. Plant Pathol. 9: 77-86.
100. Lappano, R., Rosano, C., Madeo, A., Albanito, L., Plastina, P., Gabriele, B., Forti, L., Stivala, L.A., Iacopetta, D., Dolce, V., Andò, S., Pezzi, V., and Maggiolini, M. 2009. Structure-activity relationships of resveratrol and derivatives in breast cancer cells. Mol. Nutr. Food Res. 53: 845-858.
101. Le Corre, L., Chalabi, N., Delort, L., Bignon, Y.J., and Bernard-Gallon, D.J. 2006. Differential expression of genes induced by resveratrol in human breast cancer cell lines. Nutr. Cancer 56: 193-203.
102. Lee, D.H., Szczepanski, M., and Lee, Y.J. 2008. Role of Bax in quercetin-induced apoptosis in human prostate cancer cells. Biochem. Pharmacol. 75: 2345-2355.
103. Levi, F., Pasche, C., Lucchini, F., Ghidoni, R., Ferraroni, M., and La Vecchia, C. 2005. Epidemiological evidence that resveratrol from grape is inversely related to breast can¬cer risk. Study on 369 cases vs 602 controls of Swiss women from 1993 to 2003. Eur. J. Cancer Prev. 14: 139-142.
104. Li, X., Phillips, F.M., An, H.S., Ellman, M., Thonar, E.J., Wu, W., Park, D., and Im, H.J. 2008. The action of resveratrol, a phytoestrogen found in grapes, on the intervertebral disc. Spine 33: 2586-2595.
105. Li, Y., Cao, Z., and Zhu, H. 2006. Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol. Res. 53: 6-15.
106. Liang, Y.C., Tsai, S.H., Chen, L., Lin-Shiau, S.Y., and Lin, J.K. 2003. Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem. Pharmacol. 65: 1053-1060.
107. Lin, H.Y., Lansing, L., Merillon, J.M., Davis, F.B., Tang, H.Y., Shih, A., Vitrac, X., Krisa, S., Keating, T., Cao, H.J., Bergh, J., Quackenbush, S., and Davis, P.J. 2009. Integrin αVβ3 contains a receptor site for resveratrol. FASEB J. 20: 1133-1138.
108. Lin, H.Y., Shih, A., Davis, F.B., Tang, H.Y., Martino, L.J., Bennett, J.A., and Davis, P.J. 2002. Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J. Urol. 168: 748-755.
109. Lin, H.-S., Tringali, C., Spatafora, C., Wu, C., and Ho, P.C. 2010. A simple and sensitive HPLC-UV method for the quantification of piceatannol analog 3,5,3′,4′-tetramethoxy-trans-stilbene in rat plasma and its application for a pre-clinical pharmacokinetic study. J. Pharm. Biomed. Anal. 51: 679-684.
110. Liu, H., Dong, A., Gao, C., Tan, C., Liu, H., Zu, X., and Jiang, Y. 2008. The design, synthesis, and anti-tumor mechanism study of N-phosphoryl amino acid modified resveratrol analogues. Bioorg. Med. Chem. 16: 10013-10021.
111. Lu, J., Ho, C.H., Ghai, G., and Chen, K.Y. 2001. Resveratrol analog, 3,4,5,4′-tetrahydroxystil¬bene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts. Carcinogenesis 22: 321-328.
112. Lu, Z., Zhang, Y., Liu, H., Yuan, J., Zheng, Z., and Zou, G. 2007. Transport of a cancer chemopreventive polyphenol, resveratrol: Interaction with serum albumin and hemoglobin. J. Fluoresc. 17: 580-587.
113. Ma, X., Tian, X., Huang, X., Yan, F., and Qiao, D. 2007. Resveratrol-induced mitochondrial dysfunction and apoptosis are associated with Ca2+ and mCICR-mediated MPT activa¬tion in HepG2 cells. Mol. Cell. Biochem. 302: 99-109.
114. Mahyar-Roemer, M., Katsen, A., Mestres, P., and Roemer, K. 2001. Resveratrol induces colon tumor cell apoptosis independently of p53 and preceded by epithelial differentiation, mito¬chondrial proliferation and membrane potential collapse. Int. J. Cancer 94: 615-622.
115. Mahyar-Roemer, M., Kohler, H., and Roemer, K. 2002. Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells. BMC Cancer 2: 27.
116. Mahyar-Roemer, M. and Roemer, K. 2001. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopre¬ventive and therapeutic agents. Oncogene 20: 3387-3398.
117. Maier-Salamon, A., Hagenauer, B., Reznicel, G., Szekeres, T., Thalhammer, T., and Jäger, W. 2008. Metabolism and disposition of resveratrol in the isolated perfused rat liver: Role of mrp2 in the biliary excretion of glucuronides. J. Pharma. Sci. 97: 1615-1628.
118. Mansilla, S., Bataller, M., and Portugal, J. 2006. Mitotic catastrophe as a consequence of chemotherapy. Anticancer Agents Med. Chem. 6: 589-602.
119. Marambaud, P., Zhao, H., and Davies, P. 2005. Resveratrol promotes clearance of Alzheimer’s disease amyloid-β peptides. J. Biol. Chem. 280: 37377-37382.
120. Marel, A.K., Lizard, G., Izard, J.C., Latruffe, N., and Delmas, D. 2008. Inhibitory effects of trans-resveratrol analogs molecules on the proliferation and the cell cycle progression of human colon tumoral cells. Mol. Nutr. Food Res. 52: 538-548.
121. Marier, J.-F., Vachon, P., Gritsas, A., Zhang, J., Moreau, J.-P., and Ducharme, M.P. 2002. Metabolism and disposition of resveratrol in rats: Extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther. 302: 369-373.
122. Matsuoka, A., Furuta, A., Ozaki, M., Fukuhara, K., and Miyata, N. 2001. Resveratrol, a natu¬rally occurring polyphenol, induces sister chromatid exchanges in a Chinese hamster lung (CHL) cell line. Mutat. Res. 494: 107-113.
123. Matsuoka, A., Lundin, C., Johansson, F., Sahlin, M., Fukuhara, K., Sjoberg, B.M., Jenssen, D., and Onfelt, A. 2004. Correlation of sister chromatid exchange formation through homologous recombination with ribonucleotide reductase inhibition. Mutat. Res. 547: 101-107.
124. Matsuoka, A., Takeshita, K., Furuta, A., Ozaki, M., Fukuhara, K., and Miyata, N. 2002. The 4′-hydroxy group is responsible for the in vitro cytogenetic activity of resveratrol. Mutat. Res. 521: 29-35.
125. Mazué, F., Colin, D., Gobbo, J., Wegner, M., Rescifina, A., Spatafora, C., Fasseur, D., Delmas, D., Meunier, P., Tringali, C., and Latruffe, N. 2010. Structural determination of resvera¬trol for cell proliferation inhibition potency: Experimental and docking studies of new analogs. Eur. J. Med. Chem. 45: 2972-2980.
126. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H.G., Lin, H.K., Liebermann, D.A., Hoffman, B., and Reed, J.C. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.
127. Morgan, D.O. 1995. Principles of CDK regulation. Nature 374: 131-134.
128. Murias, M., Handler, N., Erker, T., Pleban, K., Ecker, G., Saiko, P., Szekeres, T., and Jäger, W. 2004. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: Synthesis and structure-activity relationship. Bioorg. Med. Chem. 12: 5571-5578.
129. Murias, M., Luczak, M.W., Niepsuj, A., Krajka-Kuzniak, V., Zielinska-Przyjemska, M., Jagodzinski, P.P., Jäger, W., Szekeres, T., and Jodynis-Liebert, J. 2008. Cytotoxic activ¬ity of 3,3′,4,4′,5,5′-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase. Toxicol. In Vitro 22: 1361-1370.
130. Nakagawa, H., Kiyozuka, Y., Uemura, Y., Senzaki, H., Shikata, N., Hioki, K., and Tsubura, A. 2001. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. J. Cancer Res. Clin. Oncol. 127: 258-264.
131. Narayanan, B.A., Narayanan, N.K., Re, G.G., and Nixon, D.W. 2003. Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int. J. Cancer 104: 204-212.
132. Narayanan, B.A., Narayanan, N.K., Stoner, G.D., and Bullock, B.P. 2002. Interactive gene expression pattern in prostate cancer cells exposed to phenolic antioxidants. Life Sci. 70: 1821-1839.
133. Narayanan, N.K., Narayanan, B.A., and Nixon, D.W. 2004. Resveratrol-induced cell growth inhibition and apoptosis is associated with modulation of phosphoglycerate mutase B in human prostate cancer cells: Two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and mass spectrometry evaluation. Cancer Detect. Prev. 28: 443-452.
134. Niles, R.M. 2006. Resveratrol does not inhibit human melanoma xenograft tumor growth due to the rapid metabolism in athymic (nu/nu) mice. J. Nutr. 136: 2542-2546.
135. Nurse, P. 1997. Checkpoint pathways come of age. Cell 91: 865-867.
136. O’Brien, N.M., Carpenter, R., O’Callaghan, Y.C., O’Grady, M.N., and Kerry, J.P. 2006. Modulatory effects of resveratrol, citroflavan-3-ol, and plant-derived extracts on oxida¬tive stress in U937 cells. J. Med. Food 9: 187-195.
137. O’Connor, P.M., Ferris, D.K., Hoffmann, I., Jackman, J., Draetta, G., and Kohn, K.W. 1994. Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard. Proc. Natl. Acad. Sci. USA 91: 9480-9484.
138. O’Connor, P.M., Ferris, D.K., Pagano, M., Draetta, G., Pines, J., Hunter, T., Longo, D.L., and Kohn, K.W. 1993. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J. Biol. Chem. 268: 8298-8308.
139. Okawara, M., Katsuki, H., Kurimoto, E., Shibata, H., Kume, T., and Akaike, A. 2007. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem. Pharmacol. 73: 550-560.
140. Olas, B., Wachowicz, B., Nowak, P., Stochmal, A., Oleszek, W., Glowacki, R., and Bald, E. 2008. Comparative studies of the antioxidant effects of a naturally occurring resve¬ratrol analogue trans-3,3′,5,5′-tetrahydroxy-4′-methoxystilbene and resveratrol-Against oxidation and nitration of biomolecules in blood platelets. Cell. Biol. Toxicol. 24: 331-340.
141. Ovesna, Z. 2008. Antioxidant activity of resveratrol, piceatannol and 3,3′,4,4′5,5′-hexahy¬droxy-trans-stilbene in three leukemia cell lines. Oncol. Rep. 16: 617-624.
142. Pagano, M., Pepperkok, R., Lukas, J., Baldin, V., Ansorge, W., Bartek, J., and Draetta, G. 1993. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibro¬blasts. J. Cell. Biol. 121: 101-111.
143. Park, D.W., Baek, K., Kim, J.R., Lee, J.J., Ryu, S.H., Chin, B.R., and Baek, S.H. 2009. Resveratrol inhibits foam cell formation via NADPH oxidase 1-mediated reactive oxygen species and monocyte chemotactic protein-1. Exp. Mol. Med. 41: 171-179.
144. Park, C.E., Kim, M.J., Lee, J.H., Min, B.I., Bae, H., Choe, W., Kim, S.S., and Ha, J. 2007. Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase. Exp. Mol. Med. 39: 222-229.
145. Pettit, G.R., Grealish, M.P., Jung, M.K., Hamel, E., Pettit, R.K., Chapuis, J.C., and Schmidt, J.M. 2002. Antineoplastic agents. 465. Structural modification of resveratrol: Sodium resverastatin phosphate. J. Med. Chem. 45: 2534-2542.
146. Ragione, F.D., Cucciolla, V., Borriello, A., Pietra, V.D., Racioppi, L., Soldati, G., Manna, C., Galletti, P., and Zappia, V. 1998. Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem. Biophys. Res. Commun. 250: 53-58.
147. Raval, A.P., Lin, H.W., Dave, K.R., Defazio, R.A., Della Morte, D., Kim, E.J., and Perez-Pinzon, M.A. 2008. Resveratrol and ischemic preconditioning in the brain. Curr. Med. Chem. 15: 1545-1551.
148. Renaud, S. and de Longeril, M. 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526.
149. Ritz, M.F., Curin, Y., Mendelowitsch, A., and Andriantsitohaina, R. 2008. Acute treatment with red wine polyphenols protects from ischemia-induced excitotoxicity, energy failure and oxidative stress in rats. Brain Res. 1239: 226-234.
150. Rivera, H., Shibayama, M., Tsutsumi, V., Perez-Alvarez, V., and Muriel, P. 2008. Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat. J. Appl. Toxicol. 28: 147-155.
151. Rivière, C., Richard, T., Quentin, L., Krisa, S., Mérillon, J.M., and Monti, J.P. 2007. Inhibitory activity of stilbenes on Alzheimer’s β-amyloid. fibrils in vitro. Bioorg. Med. Chem. 15: 1160-1167.
152. Robb, E.L., Winkelmolen, L., Visanji, N., Brotchie, J., and Stuart, J.A. 2008. Dietary resveratrol administration increases MnSOD expression and activity in mouse brain. Biochem. Biophys. Res. Commun. 372: 254-259.
153. Roberti, M., Pizzirani, D., Simoni, D., Rondanin, R., Baruchello, R., Bonora, C., Buscami, F., Grimaudo, S., and Tolomeo, M. 2003. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents. J. Med. Chem., 46: 3546-3554.
154. Roman, V., Billard, C., Kern, C., Ferry-Dumazet, H., Izard, J.C., Mohammad, R., Mossalayi, D.M., and Kolb, J.P. 2002. Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia. Br. J. Haematol. 117: 842-851.
155. Ruan, B.F., Huang, X.F., Ding, H., Xu, C., Ge, H.M., Zhu, H.L., and Tan, R.X. 2006. Synthesis and cytotoxic evaluation of a series of resveratrol derivatives. Chem. Biodivers. 3: 975-981.
156. Rubiolo, J.A., Mithieux, G., and Vega, F.V. 2008. Resveratrol protects primary rat hepatocytes against oxidative stress damage: Activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur. J. Pharmacol. 591: 66-72.
157. Saiko, P., Szakmary, A., Jaeger, W., and Szekeres, T. 2008. Resveratrol and its analogs: Defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat. Res. 658: 68-94.
158. Sale, S., Verschoyle, R.D., Boocock, D., Jones, D.J.L., Wilsher, N., Ruparelia, K.C., Potter, G.A., Farmer, P.B., Steward, W.P., and Gescher, A.J. 2004. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resvera¬trol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene. Brit. J. Cancer 90: 736-744.
159. Savaskan, E., Olivieri, G., Meier, F., Seifritz, E., Wirz-Justice, A., and Müller-Spahn, F. 2003. Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. Gerontology 49: 380-383.
160. Schilder, Y.D., Heiss, E.H., Schachner, D., Ziegler, J., Reznicek, G., Sorescu, D., and Dirsch, V.M. 2009. NADPH oxidases 1 and 4 mediate cellular senescence induced by resvera¬trol in human endothelial cells. Free Radic. Biol. Med. 46: 1598-1606.
161. Schneider, Y., Chabert, P., Stutzmann, J., Coelho, D., Fougerousse, A., Gosse, F., Launay, J.-F., Brouillard, R., and Raul, F. 2003. Resveratrol analog (Z)-3,5,4′-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int. J. Cancer 107: 189-196.
162. Schneider, Y., Vincent, F., Duranton, B., Badolo, L., Gosse, F., Bergmann, C., Seiler, N., and Raul, F. 2000. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 158: 85-91.
163. Scifo, C., Cardile, V., Russo, A., Consoli, R., Vancheri, C., Capasso, F., Vanella, A., and Renis, M. 2004. Resveratrol and propolis as necrosis or apoptosis inducers in human prostate carcinoma cells. Oncol. Res. 14: 415-426.
164. Seiler, N., Schneider, Y., Gosse, F., Schleiffer, R., and Raul, F. 2004. Polyploidisation of meta¬static colon carcinoma cells by microtubule and tubulin interacting drugs: Effect on proteolytic activity and invasiveness. Int. J. Oncol. 25: 1039-1048.
165. Sener, G., Toklu, H.Z., Sehirli, A.O., Velioğlu-Oğünç, A., Cetinel, S., and Gedik, N. 2006. Protective effects of resveratrol against acetaminophen-induced toxicity in mice. Hepatol. Res. 35: 62-68.
166. Sengupta, B. and Sengupta, P.K. 2002. The interaction of quercetin with human serum albumin: A fluorescence spectroscopic study. Biochem. Biophys. Res. Commun. 299: 400-403.
167. She, Q.B., Bode, A.M., Ma, W.Y., Chen, N.Y., and Dong, Z. 2001. Resveratrol-induced activa¬tion of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 61: 1604-1610.
168. She, Q.B., Huang, C., Zhang, Y., and Dong, Z. 2002. Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis. Mol. Carcinog. 33: 244-250.
169. Shih, A., Davis, F.B., Lin, H.Y., and Davis, P.J. 2002. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. J. Clin. Endocrinol. Metab. 87: 1223-1232.
170. Shih, A., Zhang, S., Cao, H.J., Boswell, S., Wu, Y.H., Tang, H.Y., Lennartz, M.R., Davis, F.B., Davis, P.J., and Lin, H.Y. 2004. Inhibitory effect of epidermal growth factor on resve¬ratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-alpha. Mol. Cancer Ther. 3: 1355-1364.
171. Singh, M., Arseneault, M., Sanderson, T., Murthy, V., and Ramassamy, C. 2008. Challenges for the research on polyphenols from foods in Alzheimer’s disease: Bioavailability, metabo¬lism and cellular and molecular mechanisms. J. Agric. Food Chem. 56: 4855-4873.
172. Spatafora, C., Basini, G., Baioni, L., Grasselli, F., Sofia, A., and Tringali, C. 2009. Antiangiogenic resveratrol analogues by mild m-CPBA aromatic hydroxylation of 3,5-dimethoxystilbenes. Nat. Prod. Comm. 4: 239-246.
173. Soleas, G.J., Angelini, M., Grass, L., Diamandis, E.P., and Goldberg, D.M. 2001. Absorption of trans-resveratrol in rats. Methods Enzymol. 335: 145-154.
174. Srinivasula, S.M., Datta, P., Fan, X.J., Fernandes-Alnemri, T., Huang, Z., and Alnemri, E.S. 2000. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J. Biol. Chem. 275: 36152-36157.
175. Stivala, L.A., Savio, M., Carafoli, F., Perucca, P., Bianchi, L., Maga, G., Forti, L., Pagnoni, U.M., Albini, A., Prosperi, E., and Vannini, V. 2001. Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J. Biol. Chem. 276: 22586-22594.
176. Sun, Z.J., Pan, C.E., Liu, H.S., and Wang, G.J. 2002. Anti-hepatoma activity of resveratrol in vitro. World J. Gastroenterol. 8: 79-81.
177. Sun, N.J., Woo, S.H., Cassady, J.M., and Snapka, R.M. 1998. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia. J. Nat. Prod. 61: 362-366.
178. Surh, Y.J., Hurh, Y.J., Kang, J.Y., Lee, E., Kong, G., and Lee, S.J. 1999. Resveratrol, an antioxi¬dant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 140: 1-10.
179. Szewczuk, L.M., Forti, L., Stivala, L.A., and Penning, T.M. 2004. Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: A mechanistic approach to the design of COX-1 selective agents. J. Biol. Chem. 279: 22727-22737.
180. Szewczuk, L.M. and Penning, T.M. 2004. Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: A structure-activity relationship study. J. Nat. Prod. 67: 1777-1782.
181. Tessitore, L., Davit, A., Sarotto, I., and Caderni, G. 2000. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21: 1619-1622.
182. Tinhofer, I., Bernhard, D., Senfter, M., Anether, G., Loeffler, M., Kroemer, G., Kofler, R., Csordas, A., and Greil, R. 2001. Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J. 15: 1613-1615.
183. Traganos, F., Ardelt, B., Halko, N., Bruno, S., and Darzynkiewicz, Z. 1992. Effects of genis¬tein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res. 52: 6200-6208.
184. Tredici, G., Miloso, M., Nicolini, G., Galbiati, S., Cavaletti, G., and Bertelli, A. 1999. Resveratrol, map kinases and neuronal cells: Might wine be a neuroprotectant? Drugs Exp. Clin. Res. 25: 99-103.
185. Tsan, M.F., White, J.E., Maheshwari, J.G., Bremner, T.A., and Sacco, J. 2000. Resveratrol induces Fas signaling-independent apoptosis in THP-1 human monocytic leukaemia cells. Br. J. Haematol. 109: 405-412.
186. Tsan, M.F., White, J.E., Maheshwari, J.G., and Chikkappa, G. 2002. Anti-leukemia effect of resveratrol. Leuk. Lymphoma 43: 983-987.
187. Ungvari, Z., Orosz, Z., Rivera, A., Labinskyy, N., Xiangmin, Z., Olson, S., Podlutsky, A., and Csiszar, A. 2007. Resveratrol increases vascular oxidative stress resistance. Am. J. Physiol. Heart. Circ. Physiol. 292: H2417-H2424.
188. van Ginkel, P.R., Sareen, D., Subramanian, L., Walker, Q., Darjatmoko, S.R., Lindstrom, M.J., Kulkarni, A., Albert, D.M., and Polans, A.S. 2007. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin. Cancer Res. 13: 5162-5169.
189. Vieira de Almeida, L.M., Piñeiro, C.C., Leite, M.C., Brolese, G., Leal, R.B., Gottfried, C., and Gonçalves, C.A. 2008. Protective effects of resveratrol on hydrogen peroxide induced toxicity in primary cortical astrocyte cultures. Neurochem. Res. 33: 8-15.
190. Vitrac, X., Desmoulière, A., Brouillaud, B., Krisa, S., Deffieux, G., Barthe, N., Rosenbaum, J., and Mérillon, J.-M. 2003. Distribution of [14C]-trans-resveratrol, a cancer chemopre¬ventive polyphenol, in mouse tissues after oral administration. Life Sci. 72: 2219-2233.
191. Wang, J., Ho, L., Zhao, W., Ono, K., Rosensweig, C., Chen, L., Humala, N., Teplow, D.B., and Pasinetti, G.M. 2008. Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer’s disease. J. Neurosci. 28: 6388-6392.
192. Wang, Z., Hsieh, T.C., Zhang, Z., Ma, Y., and Wu, J.M. 2004. Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography. Biochem. Biophys. Res. Commun. 323: 743-749.
193. Wang, M., Jin, Y., and Ho, C.T. 1999. Evaluation of resveratrol derivatives as potential antioxidants and identification of a reaction product of resveratrol and 2,2-diphenyl-1-picryhydrazyl radi¬cal. J. Agric. Food Chem. 47: 3974-3977.
194. Wang, Y., Lee, K.W., Chan, F.L., Chen, S., and Leung, L.K. 2006. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicol. Sci. 92: 71-77.
195. Wang, Q., Li, H., Wang, X.W., Wu, D.C., Chen, X.Y., and Liu, J. 2003. Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells. Neurosci. Lett. 351: 83-86.
196. Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsakopoulou, V., Ross, A.J., Roth, K.A., MacGregor, G.R., Thompson, C.B., and Korsmeyer, S.J. 2001. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730.
197. Win, W., Cao, Z., Peng, X., Trush, M.A., and Li, Y. 2002. Different effects of genistein and resveratrol on oxidative DNA damage in vitro. Mutat. Res. 513: 113-120.
198. Wolter, F., Akoglu, B., Clausnitzer, A., and Stein, J. 2001. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J. Nutr. 131: 2197-2203.
199. Wolter, F., Clausnitzer, A., Akoglu, B., and Stein, J. 2002. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. J. Nutr. 132: 298-302.
200. Xiao, J.B., Chen, X.Q., Jiang, X.Y., Hilczer, M., and Tachiya, M. 2008. Probing the interaction of trans-resveratrol with bovine serum albumin: A fluorescence quenching study with Tachiya model. J. Fluoresc. 18: 671-678.
201. Yu, H. and Jove, R. 2004. The STATS of cancer-new molecular targets come of age. Nat. Rev. Cancer 4: 97-105.
202. Yu, L., Sun, Z.J., Wu, S.L., and Pan, C.E. 2003. Effect of resveratrol on cell cycle proteins in murine transplantable liver cancer. World J. Gastroenterol. 9: 2341-2343.
203. Yu, L.J., Wu, M.L., Li, H., Chen, X.Y., Wang, Q., Sun, Y., Kong, Q.Y., and Liu, J. 2008. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblas¬toma cells. Neoplasia 10: 736-744.
204. Zang, M., Xu, S., Maitland-Toolan, K.A., Zuccollo, A., Hou, X., Jiang, B., Wierzbicki, M., Verbeuren, T.J., and Cohen, R.A. 2006. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55: 2180-2191.
205. Zhang, S., Cao, H.J., Davis, F.B., Tang, H.Y., Davis, P.J., and Lin, H.Y. 2004. Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells. Br. J. Cancer 91:178-185.
206. Zheng, L.F., Wei, Q.Y., Cai, Y.J., Fang, J.G., Zhou, B., Yang, L., and Liu, Z.L. 2006. DNA damage induced by resveratrol and its synthetic analogues in the presence of Cu (II) ions: Mechanism and structure-activity relationship. Free Radic. Biol. Med. 41: 1807-1816.
207. Zhou, H.B., Chen, J.J., Wang, W.X., Cai, J.T., and Du, Q. 2005. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J. Gastroenterol. 11: 280-284.
208. Zhou, H.B., Yan, Y., Sun, Y.N., and Zhu, J.R. 2003. Resveratrol induces apoptosis in human esophageal carcinoma cells. World J. Gastroenterol. 9: 408-411.
209. Zi, X., Grasso, A.W., Kung, H.J., and Agarwal, R. 1998. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells. Cancer Res. 58: 1920-1929.
210. Zykova, T.A., Zhu, F., Zhai, X., Ma, W.Y., Ermakova, S.P., Lee, K.W., Bode, A.M., and Dong, Z. 2008. Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol. Carcinog. 47: 797-805.